These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 29397408)
21. Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study. Bondo L; Eiken P; Abrahamsen B Osteoporos Int; 2013 Jan; 24(1):245-52. PubMed ID: 22638712 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for fracture among current, persistent users of bisphosphonates. LeBlanc ES; Rosales AG; Balasubramanian A; O'Malley CD; Egbuna O; Friess D; Perrin NA Osteoporos Int; 2015 Feb; 26(2):713-25. PubMed ID: 25354654 [TBL] [Abstract][Full Text] [Related]
23. Alendronate Use and the Risk of Nonvertebral Fracture During Glucocorticoid Therapy: A Retrospective Cohort Study. Bergman J; Nordström A; Nordström P J Clin Endocrinol Metab; 2018 Jan; 103(1):306-313. PubMed ID: 29126139 [TBL] [Abstract][Full Text] [Related]
24. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034 [TBL] [Abstract][Full Text] [Related]
25. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment. Modi A; Tang J; Sen S; Díez-Pérez A Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648 [TBL] [Abstract][Full Text] [Related]
26. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia. Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920 [TBL] [Abstract][Full Text] [Related]
27. Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study. Kang JH; Keller JJ; Lin HC Osteoporos Int; 2013 Jan; 24(1):271-7. PubMed ID: 23152093 [TBL] [Abstract][Full Text] [Related]
28. Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry. Lee YK; Byun DW; Jung SM; Kwon HY; Kim HY; Kim SH; Kim TY; Jang S; Ha YC Calcif Tissue Int; 2019 Mar; 104(3):313-319. PubMed ID: 30446771 [TBL] [Abstract][Full Text] [Related]
29. Bisphosphonate Use After Hip Fracture in Older Adults: A Nationwide Retrospective Cohort Study. Nordström P; Toots A; Gustafson Y; Thorngren KG; Hommel A; Nordström A J Am Med Dir Assoc; 2017 Jun; 18(6):515-521. PubMed ID: 28238673 [TBL] [Abstract][Full Text] [Related]
30. A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke. Kang JH; Keller JJ; Lin HC Osteoporos Int; 2012 Oct; 23(10):2551-7. PubMed ID: 22270858 [TBL] [Abstract][Full Text] [Related]
32. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors. Cadarette SM; Solomon DH; Katz JN; Patrick AR; Brookhart MA Osteoporos Int; 2011 Mar; 22(3):943-54. PubMed ID: 20532481 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation. Pedersen AB; Heide-Jørgensen U; Sørensen HT; Prieto-Alhambra D; Ehrenstein V JAMA Netw Open; 2019 Apr; 2(4):e192416. PubMed ID: 31002319 [TBL] [Abstract][Full Text] [Related]
34. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232 [TBL] [Abstract][Full Text] [Related]
35. Hip fractures in users of first- vs. second-generation bisphosphonates. Mamdani M; Kopp A; Hawker G Osteoporos Int; 2007 Dec; 18(12):1595-600. PubMed ID: 17767369 [TBL] [Abstract][Full Text] [Related]
36. Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study. Clemens KK; Jeyakumar N; Ouédraogo AM; Thain J; Khan T Arch Osteoporos; 2020 Aug; 15(1):133. PubMed ID: 32816151 [TBL] [Abstract][Full Text] [Related]
37. Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study. Beall DP; Feldman RG; Gordon ML; Gruber BL; Lane JM; Valenzuela G; Yim D; Alam J; Krege JH; Krohn K Osteoporos Int; 2016 Mar; 27(3):1191-1198. PubMed ID: 26556737 [TBL] [Abstract][Full Text] [Related]
38. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective. Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131 [TBL] [Abstract][Full Text] [Related]
39. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis. Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417 [TBL] [Abstract][Full Text] [Related]
40. Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Kiran A; Cooper C; Arden NK Osteoporos Int; 2011 May; 22(5):1555-71. PubMed ID: 20694456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]